Suki
Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.
$90MSeries E
ParticipantV
Venrock
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026
Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.
Recorded funding activity
Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $434M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionEncoded Therapeutics Inc.
Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.
$275MSeries F
ParticipantGitar
Builds AI agents for code review and continuous integration workflows
$9MUndisclosed
Role not disclosedGenLogs
Provides a truck intelligence platform using roadside sensors and AI to secure freight networks
$60MSeries B
Role not disclosed